Procter & Gamble (PG) Financials

$165.66 +0.89 (+0.54%)

As of 03:58 PM Eastern

Annual Income Statements for Procter & Gamble

This table shows Procter & Gamble's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	6/30/2024	6/30/2023	6/30/2022	6/30/2021	6/30/2020	6/30/2019	6/30/2018	6/30/2017	6/30/2016	6/30/2015
Net Income / (Loss) Attributable to Common Shareholders	14,879	14,653	14,742	14,306	13,027	3,897	9,750	15,326	10,508	7,036
Consolidated Net Income / (Loss)	14,974	14,738	14,793	14,352	13,103	3,966	9,861	15,411	10,604	7,144
Net Income / (Loss) Continuing Operations	14,974	14,738	14,793	14,352	13,103	3,966	9,861	10,194	10,027	8,287
Total Pre-Tax Income	18,761	18,353	17,995	17,615	15,834	6,069	13,326	13,257	13,369	11,012
Total Operating Income	18,545	18,134	17,813	17,986	15,706	5,487	13,363	13,766	13,441	11,049
Total Gross Profit	43,191	39,246	38,030	39,010	35,700	32,916	32,400	32,420	32,390	33,693
Total Revenue	84,039	82,006	80,187	76,118	70,950	67,684	66,832	65,058	65,299	70,749
Operating Revenue	84,039	82,006	80,187	76,118	70,950	67,684	66,832	65,058	65,299	70,749
Total Cost of Revenue	40,848	42,760	42,157	37,108	35,250	34,768	34,432	32,638	32,909	37,056
Operating Cost of Revenue	40,848	42,760	42,157	37,108	35,250	34,768	34,432	32,638	32,909	37,056
Total Operating Expenses	24,646	21,112	20,217	21,024	19,994	27,429	19,037	18,654	18,949	22,644
Selling, General & Admin Expense	23,305	21,112	20,217	21,024	19,994	19,084	19,037	18,654	18,949	20,616
Impairment Charge	1,341	0.00	0.00	-	-	8,345	0.00	0.00	-	-
Total Other Income / (Expense), net	216	219	182	-371	128	582	-37	-509	-72	-37
Interest Expense	925	756	439	502	465	509	506	465	579	626
Interest & Investment Income	473	307	51	45	155	220	247	171	182	149
Other Income / (Expense), net	668	668	570	86	438	871	222	-215	325	440
Income Tax Expense	3,787	3,615	3,202	3,263	2,731	2,103	3,465	3,063	3,342	2,725
Net Income / (Loss) Attributable to Noncontrolling Interest	95	85	51	46	76	69	111	85	96	108
Basic Earnings per Share	$6.18	$6.07	$6.00	$5.69	$5.13	$1.45	$3.75	$5.80	$3.80	$2.50
Weighted Average Basic Shares Outstanding	2.35B	4.71B	4.78B	4.85B	4.97B	2.50B	2.49B	2.60B	50.04B	-16.75B
Diluted Earnings per Share	$6.02	$5.90	$5.81	$5.50	$4.96	$1.43	$3.67	$5.59	$3.69	$2.44
Weighted Average Diluted Shares Outstanding	2.35B	4.71B	4.78B	4.85B	4.97B	2.50B	2.49B	2.60B	50.04B	-16.75B
Weighted Average Basic & Diluted Shares Outstanding	2.35B	4.71B	4.78B	4.85B	4.97B	2.50B	2.49B	2.60B	50.04B	-16.75B
Cash Dividends to Common per Share	$3.83	$3.68	$3.52	$3.24	$3.03	$2.90	$2.79	$3.00	$2.66	$2.59

This table shows Procter & Gamble's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Income / (Loss) Attributable to Common Shareholders	3,769	4,630	3,959	3,136	3,754	3,468	4,521	3,384	3,397	3,933	3,939
Consolidated Net Income / (Loss)	3,793	4,659	3,987	3,144	3,781	3,493	4,556	3,392	3,424	3,959	3,963
Net Income / (Loss) Continuing Operations	3,793	4,658	3,988	3,145	3,780	3,493	4,556	3,392	3,424	3,959	3,963
Total Pre-Tax Income	4,661	5,845	5,140	3,871	4,592	4,496	5,802	4,233	4,288	4,835	4,997
Total Operating Income	4,558	5,741	5,797	3,885	4,460	4,433	5,767	4,162	4,248	4,785	4,939
Total Gross Profit	10,082	11,464	11,316	10,184	10,340	11,297	11,370	9,940	9,664	9,876	9,766
Total Revenue	19,776	21,882	21,737	20,532	20,195	21,441	21,871	20,553	20,068	20,773	20,612
Operating Revenue	19,776	21,882	21,737	20,532	20,195	21,441	21,871	20,553	20,068	20,773	20,612
Total Cost of Revenue	9,694	10,418	10,421	10,348	9,855	10,144	10,501	10,613	10,404	10,897	10,846
Operating Cost of Revenue	9,694	10,418	10,421	10,348	9,855	10,144	10,501	10,613	10,404	10,897	10,846
Total Operating Expenses	5,524	5,723	5,519	6,299	5,880	6,863	5,604	5,778	5,416	5,091	4,827
Selling, General & Admin Expense	5,524	5,723	5,519	6,299	5,880	5,522	5,604	5,778	5,416	5,091	4,827
Impairment Charge	0.00	0.00	-	-	0.00	1,341	-	-	0.00	0.00	-
Total Other Income / (Expense), net	104	103	-657	-12	131	62	35	71	40	50	58
Interest Expense	217	240	238	219	233	248	225	240	222	171	123
Interest & Investment Income	111	119	135	108	104	133	128	116	83	66	42
Other Income / (Expense), net	210	224	-554	99	260	177	132	195	179	155	139
Income Tax Expense	868	1,187	1,152	726	812	1,003	1,246	841	864	876	1,034
Net Income / (Loss) Attributable to Noncontrolling Interest	23	29	28	8.00	27	25	35	8.00	27	26	24
Basic Earnings per Share	$1.58	$1.94	$1.65	$1.29	$1.56	$1.44	$1.89	$1.41	$1.41	$1.63	$1.62
Weighted Average Basic Shares Outstanding	2.34B	2.34B	2.36B	2.35B	2.36B	2.35B	2.36B	4.71B	2.36B	2.36B	2.37B
Diluted Earnings per Share	$1.54	$1.88	$1.61	$1.27	$1.52	$1.40	$1.83	$1.37	$1.37	$1.59	$1.57
Weighted Average Diluted Shares Outstanding	2.34B	2.34B	2.36B	2.35B	2.36B	2.35B	2.36B	4.71B	2.36B	2.36B	2.37B
Weighted Average Basic & Diluted Shares Outstanding	2.34B	2.34B	2.36B	2.35B	2.36B	2.35B	2.36B	4.71B	2.36B	2.36B	2.37B
Cash Dividends to Common per Share	$1.01	$1.01	$1.01	-	$0.94	$0.94	$0.94	-	$0.91	$0.91	$0.91

This table details how cash moves in and out of Procter & Gamble's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	6/30/2024	6/30/2023	6/30/2022	6/30/2021	6/30/2020	6/30/2019	6/30/2018	6/30/2017	6/30/2016	6/30/2015
Net Change in Cash & Equivalents	1,235	1,032	-3,074	-5,893	11,942	1,758	-3,019	-2,529	266	-1,712
Net Cash From Operating Activities	19,846	16,848	16,723	18,371	17,403	15,242	14,867	12,753	15,435	14,608
Net Cash From Continuing Operating Activities	19,847	16,848	16,723	18,371	17,403	15,242	14,867	12,753	15,435	14,608
Net Income / (Loss) Continuing Operations	14,974	14,738	14,793	14,352	13,103	3,966	9,861	15,411	10,604	7,144
Consolidated Net Income / (Loss)	14,974	14,738	14,793	14,352	13,103	3,966	9,861	15,411	10,604	7,144
Depreciation Expense	2,896	2,714	2,807	2,735	3,013	2,824	2,834	2,820	3,078	3,134
Non-Cash Adjustments To Reconcile Net Income	2,657	52	41	778	-31	8,495	996	-4,434	928	4,519
Changes in Operating Assets and Liabilities, net	-680	-656	-918	506	1,318	-43	1,176	-1,044	825	-189
Net Cash From Investing Activities	-3,504	-3,500	-4,424	-2,834	3,045	-3,490	-3,511	-6,685	-5,575	-2,890
Net Cash From Continuing Investing Activities	-3,504	-3,500	-4,424	-2,834	3,045	-3,490	-3,511	-6,210	-5,575	-2,890
Purchase of Property, Plant & Equipment	-3,322	-3,062	-3,156	-2,787	-3,073	-3,347	-3,717	-3,384	-3,314	-3,736
Acquisitions	-21	-765	-1,381	-34	-58	-3,945	-109	-16	-186	-137
Sale of Property, Plant & Equipment	346	46	110	42	30	394	269	571	432	4,498
Sale and/or Maturity of Investments	-507	281	3.00	-55	6,146	3,628	3,955	1,488	1,447	1,040
Net Cash From Financing Activities	-14,855	-12,146	-14,876	-21,531	-8,367	-9,994	-14,375	-8,568	-9,213	-13,019
Net Cash From Continuing Financing Activities	-14,855	-12,146	-14,876	-21,531	-8,367	-9,994	-14,375	-8,568	-9,213	-13,019
Repayment of Debt	-9,167	-18,228	-12,904	-15,995	-14,473	-3,184	-6,310	-4,931	-2,631	-6,092
Repurchase of Common Equity	-5,006	-7,353	-10,003	-11,009	-7,405	-5,003	-7,004	-5,204	-4,004	-4,604
Payment of Dividends	-9,312	-8,999	-8,770	-8,263	-7,789	-7,498	-7,310	-7,236	-7,436	-7,287
Issuance of Debt	6,725	21,165	14,796	12,092	19,322	2,367	5,072	6,330	3,916	2,138
Other Financing Activities, net	1,905	1,269	2,005	1,644	1,978	3,324	1,177	2,473	942	2,826
Effect of Exchange Rate Changes	-251	-	-	-	-	-	-	-29	-381	-411
Cash Interest Paid	878	721	451	531	434	497	529	518	569	678
Cash Income Taxes Paid	4,363	4,278	3,818	3,822	3,550	3,064	2,830	3,714	3,730	4,558

This table details how cash moves in and out of Procter & Gamble's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Change in Cash & Equivalents	-1,113	-1,927	2,675	2,653	-1,111	-1,843	1,487	650	742	144	-504
Net Cash From Operating Activities	3,705	4,825	4,302	5,754	4,088	5,100	4,904	5,341	3,863	3,574	4,070
Net Cash From Continuing Operating Activities	3,704	4,825	4,302	5,754	4,089	5,100	4,904	5,341	3,863	3,574	4,070
Net Income / (Loss) Continuing Operations	3,793	4,659	3,987	3,144	3,781	3,493	4,556	3,392	3,424	3,959	3,963
Consolidated Net Income / (Loss)	3,793	4,659	3,987	3,144	3,781	3,493	4,556	3,392	3,424	3,959	3,963
Depreciation Expense	690	706	728	761	712	721	702	706	692	653	663
Non-Cash Adjustments To Reconcile Net Income	201	80	1,083	1,140	-442	1,735	224	10	193	-125	-26
Changes in Operating Assets and Liabilities, net	-980	-620	-1,496	709	38	-849	-578	1,233	-446	-913	-530
Net Cash From Investing Activities	-726	-921	-1,108	-518	-762	-1,002	-1,222	-798	-1,380	-490	-832
Net Cash From Continuing Investing Activities	-727	-922	-1,108	-518	-763	-1,001	-1,222	-798	-1,380	-490	-832
Purchase of Property, Plant & Equipment	-859	-925	-993	-783	-797	-817	-925	-734	-730	-708	-890
Acquisitions	-5.00	-	-6.00	-	-	-	0.00	-	-	-	-
Sale of Property, Plant & Equipment	17	2.00	45	269	69	5.00	3.00	37	1.00	3.00	5.00
Sale and/or Maturity of Investments	120	1.00	-154	-4.00	-	-189	-300	-50	-13	289	55
Net Cash From Financing Activities	-4,215	-5,571	-634	-2,499	-4,269	-6,049	-2,038	-3,893	-1,753	-2,993	-3,507
Net Cash From Continuing Financing Activities	-4,216	-5,570	-634	-2,499	-4,267	-6,052	-2,037	-3,893	-1,753	-2,993	-3,507
Repayment of Debt	-1,048	-3,669	-1,085	-1,640	670	-3,719	-738	-6,830	-4,502	-6,481	-415
Repurchase of Common Equity	-1,351	-2,510	-1,939	-1,516	-987	-1,003	-1,500	-	-1,351	-2,002	-4,000
Payment of Dividends	-2,433	-2,441	-2,445	-2,449	-2,285	-2,288	-2,290	-2,289	-2,224	-2,231	-2,255
Other Financing Activities, net	616	240	745	940	568	85	312	408	424	249	188
Effect of Exchange Rate Changes	122	-	-	-	-	-	-	-	-	-	-

This table presents Procter & Gamble's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	6/30/2024	6/30/2023	6/30/2022	6/30/2021	6/30/2020	6/30/2019	6/30/2018	6/30/2017	6/30/2016	6/30/2015
Total Assets	122,370	120,829	117,208	119,307	120,700	115,095	118,310	120,406	127,136	129,495
Total Current Assets	24,709	22,648	21,653	23,091	27,987	22,473	23,320	26,494	33,782	29,646
Cash & Equivalents	9,482	8,246	-	10,288	-	4,239	2,569	5,569	7,102	6,836
Accounts Receivable	6,118	5,471	5,143	4,725	4,178	4,951	4,686	4,594	4,373	4,568
Inventories, net	7,016	7,073	6,924	5,983	5,498	5,017	4,738	4,624	4,716	4,979
Prepaid Expenses	2,095	1,858	2,372	2,095	2,130	2,218	2,046	2,139	2,653	2,708
Plant, Property, & Equipment, net	22,152	21,909	21,195	21,686	20,692	21,271	20,600	19,893	19,385	19,655
Total Noncurrent Assets	75,508	76,272	74,360	74,530	72,021	71,351	74,390	74,019	73,969	80,194
Goodwill	40,303	40,659	39,700	40,924	39,901	40,273	45,175	44,699	44,350	44,622
Intangible Assets	22,047	23,783	23,679	23,642	23,792	24,215	23,902	24,187	24,527	25,010
Other Noncurrent Operating Assets	13,158	11,830	10,981	9,964	8,328	6,863	5,313	5,133	5,092	5,358
Total Liabilities & Shareholders' Equity	122,370	120,829	117,208	119,307	120,700	115,095	118,310	120,406	127,136	129,495
Total Liabilities	71,811	73,764	70,354	72,653	73,822	67,516	65,427	64,628	69,153	66,445
Total Current Liabilities	33,627	35,756	33,081	33,132	32,976	30,011	28,237	30,210	30,770	29,790
Short-Term Debt	7,191	10,229	8,645	8,889	11,183	9,697	10,423	13,554	11,653	12,018
Accounts Payable	15,364	14,598	14,882	13,720	12,071	11,260	10,344	9,632	9,325	8,138
Accrued Expenses	11,073	10,929	9,554	10,523	9,722	9,054	7,470	7,024	7,449	8,091
Total Noncurrent Liabilities	38,183	38,008	37,273	39,521	40,846	37,505	37,190	34,418	38,383	36,655
Long-Term Debt	25,269	24,378	22,848	23,099	23,537	20,395	20,863	18,038	18,945	18,327
Noncurrent Deferred & Payable Income Tax Liabilities	6,516	6,478	6,809	6,153	6,199	6,899	6,163	8,126	9,113	9,179
Other Noncurrent Operating Liabilities	6,398	7,152	7,616	10,269	11,110	10,211	10,164	8,254	10,325	8,432
Total Equity & Noncontrolling Interests	50,559	47,065	46,854	46,654	46,878	47,579	52,883	55,778	57,983	63,050
Total Preferred & Common Equity	50,286	46,777	46,589	46,308	46,424	47,194	52,293	55,184	57,341	62,419
Preferred Stock	798	819	843	800	800	928	967	1,006	1,038	1,077
Total Common Equity	49,488	45,958	45,746	45,508	45,624	46,266	51,326	54,178	56,303	61,342
Common Stock	71,693	70,565	69,804	68,857	68,203	67,836	67,855	67,650	67,723	67,861
Retained Earnings	123,811	118,170	112,429	106,374	100,239	94,918	98,641	96,124	87,953	84,807
Treasury Stock	-133,379	-129,736	-123,382	-114,973	-105,573	-100,406	-99,217	-93,715	-82,176	-77,226
Accumulated Other Comprehensive Income / (Loss)	-11,900	-12,220	-12,189	-13,744	-16,165	-14,936	-14,749	-14,632	-15,907	-12,780
Other Equity Adjustments	-737	-821	-916	-1,006	-1,080	-1,146	-1,204	-1,249	-1,290	-1,320
Noncontrolling Interest	272	288	265	276	357	385	590	594	642	631

This table presents Procter & Gamble's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Total Assets	122,984	122,639	126,482	122,370	119,598	120,709	122,531	120,829	119,851	117,715	116,282
Total Current Assets	24,435	25,642	27,449	24,709	22,458	23,111	24,940	22,648	22,305	21,866	22,521
Cash & Equivalents	9,116	10,230	12,156	9,482	6,828	-	-	8,246	-	-	-
Accounts Receivable	6,139	6,234	6,314	6,118	6,124	6,334	6,215	5,471	5,471	5,767	5,720
Inventories, net	7,400	7,020	7,287	7,016	7,078	7,152	7,117	7,073	7,483	7,541	7,590
Prepaid Expenses	1,780	2,158	1,692	2,095	2,428	1,736	1,875	1,858	1,755	1,704	2,501
Plant, Property, & Equipment, net	22,728	22,074	22,506	22,152	22,027	22,132	21,636	21,909	21,564	21,167	20,593
Total Noncurrent Assets	75,820	74,923	76,526	75,508	75,113	75,466	75,955	76,272	75,982	74,682	73,168
Goodwill	40,476	39,898	40,970	40,303	40,567	40,916	40,239	40,659	40,718	39,951	38,761
Intangible Assets	21,836	21,833	22,053	22,047	22,193	22,302	23,637	23,783	23,832	23,594	23,465
Other Noncurrent Operating Assets	13,508	13,192	13,503	13,158	12,353	12,248	12,079	11,830	11,432	11,137	10,942
Total Liabilities & Shareholders' Equity	122,984	122,639	126,482	122,370	119,598	120,709	122,531	120,829	119,851	117,715	116,282
Total Liabilities	70,439	71,195	74,341	71,811	69,264	71,880	74,517	73,764	74,430	72,990	71,948
Total Current Liabilities	34,248	33,797	36,420	33,627	32,340	35,950	37,158	35,756	38,030	38,746	36,618
Short-Term Debt	9,889	9,424	10,409	7,191	7,729	10,616	11,811	10,229	13,717	14,300	11,717
Accounts Payable	14,512	14,495	15,350	15,364	13,691	14,234	14,435	14,598	13,790	14,153	14,845
Accrued Expenses	9,847	9,879	10,661	11,073	10,921	11,100	10,912	10,929	10,523	10,293	10,056
Total Noncurrent Liabilities	36,191	37,399	37,921	38,183	36,923	35,929	37,360	38,008	36,400	34,244	35,330
Long-Term Debt	24,252	25,263	25,744	25,269	24,253	23,096	24,069	24,378	22,874	20,582	21,286
Noncurrent Deferred & Payable Income Tax Liabilities	6,481	6,725	6,420	6,516	6,284	6,219	6,814	6,478	6,422	6,462	6,986
Other Noncurrent Operating Liabilities	5,458	5,411	5,757	6,398	6,386	6,614	6,477	7,152	7,104	7,200	7,058
Total Equity & Noncontrolling Interests	52,545	51,443	52,141	50,559	50,333	48,829	48,014	47,065	45,421	44,725	44,334
Total Preferred & Common Equity	52,272	51,168	51,840	50,286	50,058	48,534	47,692	46,777	45,140	44,455	44,075
Preferred Stock	781	788	791	798	801	809	812	819	822	831	834
Total Common Equity	51,491	50,380	51,049	49,488	49,257	47,725	46,880	45,958	44,318	43,624	43,241
Common Stock	72,624	72,292	72,111	71,693	71,404	70,944	70,831	70,565	70,325	70,154	69,964
Retained Earnings	128,919	127,544	125,361	123,811	123,132	121,617	120,443	118,170	117,082	115,858	114,163
Treasury Stock	-138,073	-137,112	-134,823	-133,379	-132,172	-131,887	-131,029	-129,736	-130,002	-129,012	-127,205
Accumulated Other Comprehensive Income / (Loss)	-11,307	-11,637	-10,893	-11,900	-12,370	-12,167	-12,583	-12,220	-12,266	-12,506	-12,811
Other Equity Adjustments	-672	-707	-707	-737	-737	-782	-782	-821	-821	-870	-870
Noncontrolling Interest	273	275	300	272	275	294	321	288	281	270	259

This table displays calculated financial ratios and metrics derived from Procter & Gamble's official financial filings.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	6/30/2024	6/30/2023	6/30/2022	6/30/2021	6/30/2020	6/30/2019	6/30/2018	6/30/2017	6/30/2016	6/30/2015
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	2.48%	2.27%	5.35%	7.28%	4.83%	1.27%	2.73%	-0.37%	-7.70%	-4.91%
EBITDA Growth	2.76%	1.54%	1.84%	8.61%	108.64%	-44.08%	0.29%	-2.81%	15.19%	-15.28%
EBIT Growth	2.19%	2.28%	1.72%	11.94%	153.92%	-53.20%	0.25%	-1.56%	19.82%	-18.63%
NOPAT Growth	1.64%	-0.55%	-0.07%	12.75%	262.47%	-63.74%	-6.58%	5.00%	21.24%	-24.23%
Net Income Growth	1.60%	-0.37%	3.07%	9.53%	230.38%	-59.78%	-36.01%	45.33%	48.43%	-39.38%
EPS Growth	2.03%	1.55%	5.64%	10.89%	246.85%	-61.04%	-34.35%	51.49%	51.23%	-39.15%
Operating Cash Flow Growth	17.79%	0.75%	-8.97%	5.56%	14.18%	2.52%	16.58%	-17.38%	5.66%	4.66%
Free Cash Flow Firm Growth	19.73%	3.41%	1.26%	-21.70%	75.62%	-13.08%	12.11%	-38.02%	-46.60%	107.01%
Invested Capital Growth	0.15%	3.22%	4.07%	4.49%	-2.92%	-6.82%	0.12%	2.62%	-5.41%	-19.57%
Revenue Q/Q Growth	-0.03%	1.28%	0.71%	1.67%	0.86%	0.88%	0.64%	-0.04%	-0.69%	5.55%
EBITDA Q/Q Growth	-1.42%	2.85%	0.43%	-0.16%	81.39%	-44.28%	-3.54%	0.53%	10.88%	-7.42%
EBIT Q/Q Growth	-1.90%	3.37%	0.43%	0.39%	114.05%	-53.68%	-4.45%	1.54%	13.36%	-9.14%
NOPAT Q/Q Growth	-1.20%	2.25%	0.87%	0.60%	165.85%	-67.29%	0.28%	2.00%	18.36%	-15.33%
Net Income Q/Q Growth	-1.63%	2.32%	1.02%	0.86%	157.93%	-64.25%	-3.07%	1.61%	15.46%	-22.57%
EPS Q/Q Growth	-1.63%	2.79%	1.22%	1.29%	169.57%	-66.03%	-2.39%	2.38%	16.04%	-22.54%
Operating Cash Flow Q/Q Growth	2.13%	10.70%	-2.38%	-3.59%	3.91%	-0.31%	3.56%	-3.42%	0.99%	-3.42%
Free Cash Flow Firm Q/Q Growth	5.61%	14.51%	14.45%	-18.56%	4.43%	-11.93%	69.44%	-36.61%	-3.44%	550.98%
Invested Capital Q/Q Growth	-2.58%	-1.33%	0.34%	2.42%	-1.72%	-11.34%	-3.20%	2.26%	-4.94%	-7.14%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	51.39%	47.86%	47.43%	51.25%	50.32%	48.63%	48.48%	49.83%	49.60%	47.62%
EBITDA Margin	26.31%	26.24%	26.43%	27.34%	27.00%	13.57%	24.57%	25.16%	25.80%	20.67%
Operating Margin	22.07%	22.11%	22.21%	23.63%	22.14%	8.11%	19.99%	21.16%	20.58%	15.62%
EBIT Margin	22.86%	22.93%	22.93%	23.74%	22.75%	9.39%	20.33%	20.83%	21.08%	16.24%
Profit (Net Income) Margin	17.82%	17.97%	18.45%	18.85%	18.47%	5.86%	14.75%	23.69%	16.24%	10.10%
Tax Burden Percent	79.81%	80.30%	82.21%	81.48%	82.75%	65.35%	74.00%	116.25%	79.32%	64.87%
Interest Burden Percent	97.65%	97.61%	97.89%	97.47%	98.08%	95.45%	98.09%	97.83%	97.12%	95.85%
Effective Tax Rate	20.19%	19.70%	17.79%	18.52%	17.25%	34.65%	26.00%	23.10%	25.00%	24.75%
Return on Invested Capital (ROIC)	20.14%	20.15%	21.00%	21.91%	19.57%	5.13%	13.68%	14.84%	13.92%	9.96%
ROIC Less NNEP Spread (ROIC-NNEP)	20.84%	20.84%	21.65%	20.41%	20.13%	7.07%	13.53%	48.28%	18.32%	3.06%
Return on Net Nonoperating Assets (RNNOA)	10.53%	11.24%	10.64%	8.78%	8.17%	2.76%	4.47%	12.25%	3.60%	0.78%
Return on Equity (ROE)	30.68%	31.38%	31.64%	30.69%	27.74%	7.90%	18.15%	27.09%	17.52%	10.74%
Cash Return on Invested Capital (CROIC)	19.99%	16.97%	17.01%	17.52%	22.54%	12.20%	13.56%	12.26%	19.48%	31.65%
Operating Return on Assets (OROA)	15.80%	15.80%	15.54%	15.06%	13.69%	5.45%	11.38%	10.95%	10.73%	8.39%
Return on Assets (ROA)	12.31%	12.38%	12.51%	11.96%	11.11%	3.40%	8.26%	12.45%	8.26%	5.22%
Return on Common Equity (ROCE)	29.99%	30.64%	30.88%	29.90%	26.99%	7.67%	17.62%	26.31%	17.03%	10.45%
Return on Equity Simple (ROE_SIMPLE)	29.78%	31.51%	31.75%	30.99%	28.22%	8.40%	18.86%	27.93%	18.49%	11.45%
Net Operating Profit after Tax (NOPAT)	14,802	14,562	14,643	14,654	12,997	3,586	9,888	10,585	10,081	8,315
NOPAT Margin	17.61%	17.76%	18.26%	19.25%	18.32%	5.30%	14.80%	16.27%	15.44%	11.75%
Net Nonoperating Expense Percent (NNEP)	-0.70%	-0.69%	-0.65%	1.50%	-0.55%	-1.94%	0.15%	-33.44%	-4.40%	6.91%
Cost of Revenue to Revenue	48.61%	52.14%	52.57%	48.75%	49.68%	51.37%	51.52%	50.17%	50.40%	52.38%
SG&A Expenses to Revenue	27.73%	25.74%	25.21%	27.62%	28.18%	28.20%	28.48%	28.67%	29.02%	29.14%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	29.33%	25.74%	25.21%	27.62%	28.18%	40.53%	28.48%	28.67%	29.02%	32.01%
Earnings before Interest and Taxes (EBIT)	19,213	18,802	18,383	18,072	16,144	6,358	13,585	13,551	13,766	11,489
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	22,109	21,516	21,190	20,807	19,157	9,182	16,419	16,371	16,844	14,623
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	7.82	7.54	7.12	6.78	5.91	5.28	3.29	3.43	3.23	2.70
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	4.60	4.23	4.06	4.05	3.80	3.61	2.53	2.85	2.79	2.34
Price to Earnings (P/E)	26.00	23.66	22.10	21.57	20.71	62.73	17.32	12.11	17.32	23.55
Dividend Yield	2.34%	2.50%	2.59%	2.57%	2.78%	2.97%	4.15%	3.72%	4.86%	4.25%
Earnings Yield	3.85%	4.23%	4.53%	4.64%	4.83%	1.59%	5.77%	8.25%	5.77%	4.25%
Enterprise Value to Invested Capital (EV/IC)	5.59	5.09	4.94	4.85	4.43	3.94	2.62	2.82	2.85	2.50
Enterprise Value to Revenue (EV/Rev)	4.89	4.56	4.38	4.35	4.08	3.92	2.84	3.13	3.08	2.63
Enterprise Value to EBITDA (EV/EBITDA)	18.59	17.39	16.57	15.92	15.11	28.92	11.56	12.44	11.93	12.73
Enterprise Value to EBIT (EV/EBIT)	21.39	19.90	19.10	18.33	17.94	41.77	13.97	15.03	14.60	16.20
Enterprise Value to NOPAT (EV/NOPAT)	27.76	25.69	23.98	22.61	22.28	74.06	19.20	19.25	19.93	22.39
Enterprise Value to Operating Cash Flow (EV/OCF)	20.71	22.20	21.00	18.03	16.64	17.42	12.77	15.97	13.02	12.74
Enterprise Value to Free Cash Flow (EV/FCFF)	27.98	30.49	29.60	28.27	19.35	31.17	19.37	23.30	14.24	7.05
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.64	0.74	0.67	0.69	0.74	0.63	0.59	0.57	0.53	0.48
Long-Term Debt to Equity	0.50	0.52	0.49	0.50	0.50	0.43	0.39	0.32	0.33	0.29
Financial Leverage	0.51	0.54	0.49	0.43	0.41	0.39	0.33	0.25	0.20	0.25
Leverage Ratio	2.49	2.53	2.53	2.57	2.50	2.32	2.20	2.18	2.12	2.06
Compound Leverage Factor	2.43	2.47	2.48	2.50	2.45	2.22	2.16	2.13	2.06	1.97
Debt to Total Capital	39.10%	42.37%	40.20%	40.68%	42.55%	38.74%	37.17%	36.16%	34.54%	32.49%
Short-Term Debt to Total Capital	8.66%	12.52%	11.03%	11.30%	13.71%	12.48%	12.38%	15.51%	13.16%	12.87%
Long-Term Debt to Total Capital	30.44%	29.85%	29.16%	29.37%	28.85%	26.26%	24.79%	20.65%	21.39%	19.62%
Preferred Equity to Total Capital	0.96%	1.00%	1.08%	1.02%	0.98%	1.19%	1.15%	1.15%	1.17%	1.15%
Noncontrolling Interests to Total Capital	0.33%	0.35%	0.34%	0.35%	0.44%	0.50%	0.70%	0.68%	0.72%	0.68%
Common Equity to Total Capital	59.61%	56.27%	58.39%	57.87%	55.91%	59.57%	60.98%	62.01%	63.56%	65.68%
Debt to EBITDA	1.47	1.61	1.49	1.54	1.81	3.28	1.91	1.93	1.82	2.08
Net Debt to EBITDA	1.04	1.23	1.15	1.04	0.97	2.16	1.18	1.01	1.02	1.28
Long-Term Debt to EBITDA	1.14	1.13	1.08	1.11	1.23	2.22	1.27	1.10	1.12	1.25
Debt to NOPAT	2.19	2.38	2.15	2.18	2.67	8.39	3.16	2.98	3.04	3.65
Net Debt to NOPAT	1.55	1.81	1.66	1.48	1.43	5.52	1.97	1.55	1.71	2.25
Long-Term Debt to NOPAT	1.71	1.67	1.56	1.58	1.81	5.69	2.11	1.70	1.88	2.20
Altman Z-Score	5.77	5.25	5.21	4.83	4.34	4.02	3.61	3.72	3.45	3.25
Noncontrolling Interest Sharing Ratio	2.23%	2.36%	2.41%	2.57%	2.72%	2.86%	2.91%	2.88%	2.80%	2.69%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	0.73	0.63	0.65	0.70	0.85	0.75	0.83	0.88	1.10	1.00
Quick Ratio	0.46	0.38	0.16	0.45	0.13	0.51	0.59	0.65	0.58	0.54
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	14,690	12,269	11,864	11,717	14,964	8,521	9,802	8,743	14,106	26,417
Operating Cash Flow to CapEx	666.87%	558.62%	549.02%	669.25%	571.90%	516.15%	431.18%	453.36%	535.57%	0.00%
Free Cash Flow to Firm to Interest Expense	15.88	16.23	27.03	23.34	32.18	16.74	19.37	18.80	24.36	42.20
Operating Cash Flow to Interest Expense	21.46	22.29	38.09	36.60	37.43	29.95	29.38	27.43	26.66	23.34
Operating Cash Flow Less CapEx to Interest Expense	18.24	18.30	31.15	31.13	30.88	24.14	22.57	21.38	21.68	24.55
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.69	0.69	0.68	0.63	0.60	0.58	0.56	0.53	0.51	0.52
Accounts Receivable Turnover	14.50	15.45	16.25	17.10	15.54	14.05	14.40	14.51	14.61	12.92
Inventory Turnover	5.80	6.11	6.53	6.46	6.70	7.13	7.36	6.99	6.79	6.31
Fixed Asset Turnover	3.81	3.81	3.74	3.59	3.38	3.23	3.30	3.31	3.35	3.37
Accounts Payable Turnover	2.73	2.90	2.95	2.88	3.02	3.22	3.45	3.44	3.77	4.46
Days Sales Outstanding (DSO)	25.17	23.62	22.46	21.35	23.48	25.98	25.34	25.15	24.99	28.26
Days Inventory Outstanding (DIO)	62.95	59.74	55.88	56.46	54.44	51.20	49.62	52.23	53.76	57.81
Days Payable Outstanding (DPO)	133.86	125.82	123.82	126.84	120.79	113.40	105.88	106.00	96.84	81.75
Cash Conversion Cycle (CCC)	-45.75	-42.46	-45.49	-49.03	-42.87	-36.21	-30.92	-28.62	-18.09	4.32
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	73,538	73,426	71,133	68,354	65,417	67,384	72,319	72,233	70,391	74,416
Invested Capital Turnover	1.14	1.13	1.15	1.14	1.07	0.97	0.92	0.91	0.90	0.85
Increase / (Decrease) in Invested Capital	112	2,293	2,779	2,937	-1,967	-4,935	86	1,842	-4,025	-18,102
Enterprise Value (EV)	410,956	374,097	351,159	331,297	289,544	265,560	189,826	203,721	200,934	186,145
Market Capitalization	386,908	346,629	325,772	308,521	269,848	244,442	168,833	185,666	182,004	165,695
Book Value per Share	$20.97	$19.50	$19.07	$18.59	$18.43	$18.44	$20.41	$21.18	$21.15	$22.61
Tangible Book Value per Share	($5.45)	($7.84)	($7.35)	($7.78)	($7.30)	($7.26)	($7.06)	($5.75)	($4.72)	($3.06)
Total Capital	83,019	81,672	78,347	78,642	81,598	77,671	84,169	87,370	88,581	93,395
Total Debt	32,460	34,607	31,493	31,988	34,720	30,092	31,286	31,592	30,598	30,345
Total Long-Term Debt	25,269	24,378	22,848	23,099	23,537	20,395	20,863	18,038	18,945	18,327
Net Debt	22,978	26,361	24,279	21,700	18,539	19,805	19,436	16,455	17,250	18,742
Capital Expenditures (CapEx)	2,976	3,016	3,046	2,745	3,043	2,953	3,448	2,813	2,882	-762
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-11,209	-11,125	-9,997	-11,440	-9,987	-8,128	-6,344	-5,299	1,317	271
Debt-free Net Working Capital (DFNWC)	-1,727	-2,879	-2,783	-1,152	6,194	2,159	5,506	9,838	14,665	11,874
Net Working Capital (NWC)	-8,918	-13,108	-11,428	-10,041	-4,989	-7,538	-4,917	-3,716	3,012	-144
Net Nonoperating Expense (NNE)	-172	-176	-150	302	-106	-380	27	-4,826	-523	1,171
Net Nonoperating Obligations (NNO)	22,979	26,361	24,279	21,700	18,539	19,805	19,436	16,455	12,408	11,366
Total Depreciation and Amortization (D&A)	2,896	2,714	2,807	2,735	3,013	2,824	2,834	2,820	3,078	3,134
Debt-free, Cash-free Net Working Capital to Revenue	-13.34%	-13.57%	-12.47%	-15.03%	-14.08%	-12.01%	-9.49%	-8.15%	2.02%	0.38%
Debt-free Net Working Capital to Revenue	-2.06%	-3.51%	-3.47%	-1.51%	8.73%	3.19%	8.24%	15.12%	22.46%	16.78%
Net Working Capital to Revenue	-10.61%	-15.98%	-14.25%	-13.19%	-7.03%	-11.14%	-7.36%	-5.71%	4.61%	-0.20%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$6.18	$6.07	$6.00	$5.69	$5.13	$1.45	$0.00	$5.80	$3.80	$2.50
Adjusted Weighted Average Basic Shares Outstanding	2.35B	4.71B	4.78B	4.85B	4.97B	2.50B	0.00	2.55B	2.67B	2.71B
Adjusted Diluted Earnings per Share	$6.02	$5.90	$5.81	$5.50	$4.96	$1.43	$0.00	$5.59	$3.69	$2.44
Adjusted Weighted Average Diluted Shares Outstanding	2.35B	4.71B	4.78B	4.85B	4.97B	2.50B	0.00	2.55B	2.67B	2.71B
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	2.35B	4.71B	4.78B	4.85B	4.97B	2.50B	0.00	2.55B	2.67B	2.71B
Normalized Net Operating Profit after Tax (NOPAT)	15,872	14,562	14,643	14,654	12,997	9,039	9,888	10,585	10,081	8,315
Normalized NOPAT Margin	18.89%	17.76%	18.26%	19.25%	18.32%	13.35%	14.80%	16.27%	15.44%	11.75%
Pre Tax Income Margin	22.32%	22.38%	22.44%	23.14%	22.32%	8.97%	19.94%	20.38%	20.47%	15.56%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	20.77	24.87	41.87	36.00	34.72	12.49	26.85	29.14	23.78	18.35
NOPAT to Interest Expense	16.00	19.26	33.36	29.19	27.95	7.04	19.54	22.76	17.41	13.28
EBIT Less CapEx to Interest Expense	17.55	20.88	34.94	30.53	28.17	6.69	20.03	23.09	18.80	19.57
NOPAT Less CapEx to Interest Expense	12.78	15.27	26.42	23.72	21.41	1.24	12.73	16.71	12.43	14.50
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	62.19%	61.06%	59.28%	57.57%	59.44%	189.06%	74.13%	46.95%	70.12%	102.00%
Augmented Payout Ratio	95.62%	110.95%	126.90%	134.28%	115.96%	315.20%	145.16%	80.72%	107.88%	166.45%

This table displays calculated financial ratios and metrics derived from Procter & Gamble's official financial filings.

Metric	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-2.07%	2.06%	-0.61%	-0.10%	0.63%	3.22%	6.11%	5.32%	3.54%	-0.86%	1.35%
EBITDA Growth	0.48%	25.14%	-9.54%	-6.28%	6.11%	-4.68%	14.98%	13.37%	5.31%	-7.08%	-1.76%
EBIT Growth	1.02%	29.39%	-11.12%	-8.56%	6.62%	-6.68%	16.17%	16.37%	6.14%	-7.40%	-1.07%
NOPAT Growth	1.03%	32.84%	-0.68%	-5.36%	8.23%	-12.10%	15.61%	10.64%	1.92%	-6.37%	-4.84%
Net Income Growth	0.32%	33.38%	-12.49%	-7.31%	10.43%	-11.77%	14.96%	10.92%	1.69%	-6.67%	-3.95%
EPS Growth	1.32%	34.29%	-12.02%	-7.30%	10.95%	-11.95%	16.56%	13.22%	3.01%	-4.22%	-2.48%
Operating Cash Flow Growth	-9.37%	-5.39%	-12.28%	7.73%	5.82%	42.70%	20.49%	43.85%	19.01%	-30.21%	-12.34%
Free Cash Flow Firm Growth	-37.36%	115.61%	153.21%	192.14%	2,026.29%	824.26%	-46.91%	342.63%	83.60%	-94.20%	-20.89%
Invested Capital Growth	2.76%	1.67%	2.67%	0.15%	1.44%	2.61%	5.00%	3.22%	4.98%	5.44%	2.98%
Revenue Q/Q Growth	-9.62%	0.67%	5.87%	1.67%	-5.81%	-1.97%	6.41%	2.42%	-3.39%	0.78%	5.62%
EBITDA Q/Q Growth	-18.18%	11.72%	25.84%	-12.65%	1.89%	-19.24%	30.38%	-1.09%	-8.47%	-2.58%	28.55%
EBIT Q/Q Growth	-20.07%	13.77%	31.60%	-15.59%	2.39%	-21.85%	35.39%	-1.58%	-10.38%	-2.72%	35.63%
NOPAT Q/Q Growth	-18.93%	1.72%	42.50%	-14.03%	6.60%	-23.95%	35.78%	-1.68%	-13.43%	0.03%	29.94%
Net Income Q/Q Growth	-18.59%	16.85%	26.81%	-16.85%	8.25%	-23.33%	34.32%	-0.93%	-13.51%	-0.10%	29.59%
EPS Q/Q Growth	-18.09%	16.77%	26.77%	-16.45%	8.57%	-23.50%	33.58%	0.00%	-13.84%	1.27%	29.75%
Operating Cash Flow Q/Q Growth	-23.21%	12.16%	-25.23%	40.75%	-19.84%	4.00%	-8.18%	38.26%	8.09%	-12.19%	9.61%
Free Cash Flow Firm Q/Q Growth	-51.09%	32.07%	-17.20%	17.12%	68.35%	55.10%	-4.47%	872.27%	-180.77%	-91.09%	696.40%
Invested Capital Q/Q Growth	2.20%	-0.31%	3.53%	-2.58%	1.12%	0.66%	1.00%	-1.33%	2.29%	3.01%	-0.71%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	50.98%	52.39%	52.06%	49.60%	51.20%	52.69%	51.99%	48.36%	48.16%	47.54%	47.38%
EBITDA Margin	27.60%	30.49%	27.47%	23.11%	26.90%	24.86%	30.18%	24.63%	25.51%	26.92%	27.85%
Operating Margin	23.05%	26.24%	26.67%	18.92%	22.08%	20.68%	26.37%	20.25%	21.17%	23.03%	23.96%
EBIT Margin	24.11%	27.26%	24.12%	19.40%	23.37%	21.50%	26.97%	21.20%	22.06%	23.78%	24.64%
Profit (Net Income) Margin	19.18%	21.29%	18.34%	15.31%	18.72%	16.29%	20.83%	16.50%	17.06%	19.06%	19.23%
Tax Burden Percent	81.38%	79.71%	77.57%	81.22%	82.34%	77.69%	78.52%	80.13%	79.85%	81.88%	79.31%
Interest Burden Percent	97.76%	97.99%	98.04%	97.16%	97.29%	97.53%	98.36%	97.15%	96.86%	97.87%	98.40%
Effective Tax Rate	18.62%	20.31%	22.41%	18.75%	17.68%	22.31%	21.48%	19.87%	20.15%	18.12%	20.69%
Return on Invested Capital (ROIC)	20.57%	23.43%	23.10%	17.58%	20.39%	18.29%	23.82%	18.41%	18.84%	21.36%	21.97%
ROIC Less NNEP Spread (ROIC-NNEP)	20.90%	23.76%	21.07%	17.53%	20.79%	18.47%	23.92%	18.64%	18.96%	21.52%	22.16%
Return on Net Nonoperating Assets (RNNOA)	10.20%	11.91%	10.55%	8.86%	11.76%	10.63%	13.58%	10.05%	11.26%	12.52%	11.84%
Return on Equity (ROE)	30.76%	35.34%	33.65%	26.44%	32.15%	28.93%	37.40%	28.46%	30.09%	33.88%	33.80%
Cash Return on Invested Capital (CROIC)	18.13%	19.49%	17.04%	19.99%	18.56%	17.37%	16.08%	16.97%	14.75%	14.71%	17.82%
Operating Return on Assets (OROA)	16.68%	18.90%	16.25%	13.41%	16.41%	15.14%	18.81%	14.61%	14.88%	15.97%	16.80%
Return on Assets (ROA)	13.27%	14.76%	12.36%	10.58%	13.15%	11.47%	14.53%	11.37%	11.51%	12.80%	13.11%
Return on Common Equity (ROCE)	30.13%	34.58%	32.90%	25.85%	31.42%	28.24%	36.50%	27.79%	29.36%	33.04%	32.96%
Return on Equity Simple (ROE_SIMPLE)	29.81%	30.43%	27.79%	0.00%	30.41%	30.63%	32.15%	0.00%	31.91%	32.27%	33.19%
Net Operating Profit after Tax (NOPAT)	3,709	4,575	4,498	3,156	3,671	3,444	4,529	3,335	3,392	3,918	3,917
NOPAT Margin	18.76%	20.91%	20.69%	15.37%	18.18%	16.06%	20.71%	16.23%	16.90%	18.86%	19.00%
Net Nonoperating Expense Percent (NNEP)	-0.33%	-0.33%	2.04%	0.05%	-0.41%	-0.18%	-0.10%	-0.22%	-0.12%	-0.16%	-0.19%
Return On Investment Capital (ROIC_SIMPLE)	4.28%	5.31%	-	-	-	4.17%	-	-	-	-	-
Cost of Revenue to Revenue	49.02%	47.61%	47.94%	50.40%	48.80%	47.31%	48.01%	51.64%	51.84%	52.46%	52.62%
SG&A Expenses to Revenue	27.93%	26.15%	25.39%	30.68%	29.12%	25.75%	25.62%	28.11%	26.99%	24.51%	23.42%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	27.93%	26.15%	25.39%	30.68%	29.12%	32.01%	25.62%	28.11%	26.99%	24.51%	23.42%
Earnings before Interest and Taxes (EBIT)	4,768	5,965	5,243	3,984	4,720	4,610	5,899	4,357	4,427	4,940	5,078
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	5,458	6,671	5,971	4,745	5,432	5,331	6,601	5,063	5,119	5,593	5,741
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	7.71	7.84	7.94	7.82	7.70	7.06	7.11	7.54	7.67	7.98	6.71
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	4.73	4.68	4.83	4.60	4.51	4.02	4.00	4.23	4.20	4.34	3.61
Price to Earnings (P/E)	25.63	25.51	28.31	26.00	25.08	22.82	21.88	23.66	23.73	24.38	19.93
Dividend Yield	2.38%	2.36%	2.26%	2.34%	2.33%	2.61%	2.62%	2.50%	2.54%	2.46%	2.94%
Earnings Yield	3.90%	3.92%	3.53%	3.85%	3.99%	4.38%	4.57%	4.23%	4.21%	4.10%	5.02%
Enterprise Value to Invested Capital (EV/IC)	5.46	5.54	5.65	5.59	5.37	4.87	4.86	5.09	4.97	5.18	4.50
Enterprise Value to Revenue (EV/Rev)	5.04	4.98	5.13	4.89	4.82	4.34	4.33	4.56	4.57	4.70	3.95
Enterprise Value to EBITDA (EV/EBITDA)	18.53	18.42	20.04	18.59	18.08	16.46	16.12	17.39	17.69	18.26	15.07
Enterprise Value to EBIT (EV/EBIT)	21.20	21.11	23.19	21.39	20.71	18.86	18.38	19.90	20.34	21.03	17.33
Enterprise Value to NOPAT (EV/NOPAT)	26.53	26.40	29.11	27.76	27.07	24.76	23.77	25.69	25.98	26.60	21.99
Enterprise Value to Operating Cash Flow (EV/OCF)	22.77	22.16	22.37	20.71	20.87	18.95	20.40	22.20	24.31	25.83	19.67
Enterprise Value to Free Cash Flow (EV/FCFF)	30.51	28.65	33.61	27.98	29.16	28.43	30.98	30.49	34.53	36.18	25.62
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.65	0.67	0.69	0.64	0.64	0.69	0.75	0.74	0.81	0.78	0.74
Long-Term Debt to Equity	0.46	0.49	0.49	0.50	0.48	0.47	0.50	0.52	0.50	0.46	0.48
Financial Leverage	0.49	0.50	0.50	0.51	0.57	0.58	0.57	0.54	0.59	0.58	0.53
Leverage Ratio	2.36	2.43	2.49	2.49	2.50	2.55	2.59	2.53	2.63	2.67	2.60
Compound Leverage Factor	2.31	2.38	2.44	2.42	2.43	2.49	2.54	2.46	2.55	2.61	2.56
Debt to Total Capital	39.38%	40.27%	40.95%	39.10%	38.85%	40.84%	42.77%	42.37%	44.62%	43.82%	42.67%
Short-Term Debt to Total Capital	11.41%	10.94%	11.79%	8.66%	9.39%	12.86%	14.08%	12.52%	16.73%	17.96%	15.15%
Long-Term Debt to Total Capital	27.98%	29.33%	29.16%	30.44%	29.46%	27.98%	28.69%	29.85%	27.89%	25.85%	27.52%
Preferred Equity to Total Capital	0.90%	0.91%	0.90%	0.96%	0.97%	0.98%	0.97%	1.00%	1.00%	1.04%	1.08%
Noncontrolling Interests to Total Capital	0.31%	0.32%	0.34%	0.33%	0.33%	0.36%	0.38%	0.35%	0.34%	0.34%	0.33%
Common Equity to Total Capital	59.40%	58.49%	57.82%	59.61%	59.84%	57.82%	55.88%	56.27%	54.04%	54.80%	55.91%
Debt to EBITDA	1.49	1.52	1.68	1.47	1.43	1.52	1.60	1.61	1.75	1.69	1.57
Net Debt to EBITDA	1.10	1.07	1.12	1.04	1.12	1.17	1.17	1.23	1.39	1.36	1.25
Long-Term Debt to EBITDA	1.06	1.11	1.20	1.14	1.08	1.04	1.08	1.13	1.09	1.00	1.01
Debt to NOPAT	2.14	2.18	2.45	2.19	2.13	2.29	2.36	2.38	2.57	2.46	2.28
Net Debt to NOPAT	1.57	1.54	1.62	1.55	1.68	1.76	1.72	1.81	2.04	1.98	1.82
Long-Term Debt to NOPAT	1.52	1.59	1.74	1.71	1.62	1.57	1.59	1.67	1.61	1.45	1.47
Altman Z-Score	5.57	5.55	5.37	5.36	5.46	4.92	4.78	4.86	4.75	4.89	4.49
Noncontrolling Interest Sharing Ratio	2.07%	2.16%	2.22%	2.23%	2.28%	2.36%	2.41%	2.36%	2.43%	2.49%	2.48%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	0.71	0.76	0.75	0.73	0.69	0.64	0.67	0.63	0.59	0.56	0.62
Quick Ratio	0.45	0.49	0.51	0.46	0.40	0.18	0.17	0.38	0.14	0.15	0.16
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	1,628	3,329	2,521	3,044	2,599	1,544	996	1,042	-135	167	1,875
Operating Cash Flow to CapEx	440.02%	522.75%	453.80%	1,119.46%	561.54%	628.08%	531.89%	766.28%	529.90%	506.95%	459.89%
Free Cash Flow to Firm to Interest Expense	7.50	13.87	10.59	13.90	11.16	6.23	4.42	4.34	-0.61	0.98	15.24
Operating Cash Flow to Interest Expense	17.07	20.10	18.08	26.27	17.55	20.56	21.80	22.25	17.40	20.90	33.09
Operating Cash Flow Less CapEx to Interest Expense	13.19	16.26	14.09	23.93	14.42	17.29	17.70	19.35	14.12	16.78	25.89
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.69	0.69	0.67	0.69	0.70	0.70	0.70	0.69	0.67	0.67	0.68
Accounts Receivable Turnover	13.69	13.42	13.39	14.50	14.50	13.87	13.95	15.45	14.74	14.59	14.14
Inventory Turnover	5.65	5.79	5.66	5.80	5.65	5.67	5.77	6.11	5.89	6.03	6.14
Fixed Asset Turnover	3.75	3.82	3.80	3.81	3.86	3.88	3.94	3.81	3.78	3.78	3.83
Accounts Payable Turnover	2.90	2.86	2.74	2.73	2.99	2.94	2.90	2.90	3.07	3.03	2.93
Days Sales Outstanding (DSO)	26.67	27.19	27.25	25.17	25.17	26.31	26.16	23.62	24.76	25.02	25.82
Days Inventory Outstanding (DIO)	64.63	63.02	64.48	62.95	64.64	64.36	63.28	59.74	61.97	60.51	59.48
Days Payable Outstanding (DPO)	125.90	127.75	133.33	133.86	121.99	124.35	125.98	125.82	118.83	120.50	124.42
Cash Conversion Cycle (CCC)	-34.60	-37.54	-41.60	-45.75	-32.18	-33.67	-36.54	-42.46	-32.10	-34.97	-39.12
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	77,569	75,899	76,137	73,538	75,488	74,653	74,160	73,426	74,416	72,753	70,627
Invested Capital Turnover	1.10	1.12	1.12	1.14	1.12	1.14	1.15	1.13	1.11	1.13	1.16
Increase / (Decrease) in Invested Capital	2,081	1,246	1,977	112	1,072	1,900	3,533	2,293	3,527	3,751	2,042
Enterprise Value (EV)	423,214	420,343	430,428	410,956	405,560	363,917	360,665	374,097	369,990	377,192	317,693
Market Capitalization	397,135	394,823	405,340	386,908	379,330	336,992	333,385	346,629	339,892	348,063	290,307
Book Value per Share	$21.96	$21.39	$21.69	$20.97	$20.93	$20.25	$19.89	$19.50	$18.79	$18.41	$18.10
Tangible Book Value per Share	($4.61)	($4.82)	($5.09)	($5.45)	($5.74)	($6.57)	($7.21)	($7.84)	($8.58)	($8.41)	($7.95)
Total Capital	86,686	86,130	88,294	83,019	82,315	82,541	83,894	81,672	82,012	79,607	77,337
Total Debt	34,141	34,687	36,153	32,460	31,982	33,712	35,880	34,607	36,591	34,882	33,003
Total Long-Term Debt	24,252	25,263	25,744	25,269	24,253	23,096	24,069	24,378	22,874	20,582	21,286
Net Debt	25,025	24,457	23,997	22,978	25,154	25,822	26,147	26,361	28,995	28,028	26,293
Capital Expenditures (CapEx)	842	923	948	514	728	812	922	697	729	705	885
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-9,040	-8,961	-10,718	-11,209	-8,981	-10,113	-10,140	-11,125	-9,604	-9,434	-9,090
Debt-free Net Working Capital (DFNWC)	76	1,269	1,438	-1,727	-2,153	-2,223	-407	-2,879	-2,008	-2,580	-2,380
Net Working Capital (NWC)	-9,813	-8,155	-8,971	-8,918	-9,882	-12,839	-12,218	-13,108	-15,725	-16,880	-14,097
Net Nonoperating Expense (NNE)	-84	-84	511	12	-110	-49	-27	-57	-32	-41	-46
Net Nonoperating Obligations (NNO)	25,024	24,456	23,996	22,979	25,155	25,824	26,146	26,361	28,995	28,028	26,293
Total Depreciation and Amortization (D&A)	690	706	728	761	712	721	702	706	692	653	663
Debt-free, Cash-free Net Working Capital to Revenue	-10.77%	-10.62%	-12.77%	-13.34%	-10.68%	-12.05%	-12.18%	-13.57%	-11.86%	-11.75%	-11.30%
Debt-free Net Working Capital to Revenue	0.09%	1.50%	1.71%	-2.06%	-2.56%	-2.65%	-0.49%	-3.51%	-2.48%	-3.21%	-2.96%
Net Working Capital to Revenue	-11.69%	-9.67%	-10.69%	-10.61%	-11.76%	-15.30%	-14.67%	-15.98%	-19.42%	-21.03%	-17.52%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$1.58	$1.94	$1.65	$1.29	$1.56	$1.44	$1.89	$1.41	$1.41	$1.63	$1.62
Adjusted Weighted Average Basic Shares Outstanding	2.34B	2.34B	2.36B	2.35B	2.36B	2.35B	2.36B	4.71B	2.36B	2.36B	2.37B
Adjusted Diluted Earnings per Share	$1.54	$1.88	$1.61	$1.27	$1.52	$1.40	$1.83	$1.37	$1.37	$1.59	$1.57
Adjusted Weighted Average Diluted Shares Outstanding	2.34B	2.34B	2.36B	2.35B	2.36B	2.35B	2.36B	4.71B	2.47B	2.48B	2.50B
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	2.34B	2.34B	2.36B	2.35B	2.36B	2.35B	2.36B	4.71B	2.36B	2.36B	2.37B
Normalized Net Operating Profit after Tax (NOPAT)	3,709	4,575	4,498	3,156	3,671	4,486	4,529	3,335	3,392	3,918	3,917
Normalized NOPAT Margin	18.76%	20.91%	20.69%	15.37%	18.18%	20.92%	20.71%	16.23%	16.90%	18.86%	19.00%
Pre Tax Income Margin	23.57%	26.71%	23.65%	18.85%	22.74%	20.97%	26.53%	20.60%	21.37%	23.28%	24.24%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	21.97	24.85	22.03	18.19	20.26	18.59	26.22	18.15	19.94	28.89	41.28
NOPAT to Interest Expense	17.09	19.06	18.90	14.41	15.76	13.89	20.13	13.90	15.28	22.91	31.85
EBIT Less CapEx to Interest Expense	18.09	21.01	18.05	15.84	17.13	15.31	22.12	15.25	16.66	24.77	34.09
NOPAT Less CapEx to Interest Expense	13.21	15.22	14.91	12.07	12.63	10.61	16.03	10.99	12.00	18.79	24.65
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	62.68%	61.78%	65.72%	62.19%	60.12%	61.16%	58.93%	61.06%	62.29%	62.05%	60.44%
Augmented Payout Ratio	109.63%	106.43%	103.52%	95.62%	83.05%	87.08%	90.58%	110.95%	122.01%	121.31%	137.36%

Frequently Asked Questions About Procter & Gamble's Financials

When does Procter & Gamble's financial year end?

According to the most recent income statement we have on file, Procter & Gamble's fiscal year ends in June. Their fiscal year 2024 ended on June 30, 2024.

How has Procter & Gamble's net income changed over the last 9 years?

Procter & Gamble's net income appears to be on an upward trend, with a most recent value of $14.97 billion in 2024, rising from $7.14 billion in 2015. The previous period was $14.74 billion in 2023. See where experts think Procter & Gamble is headed by visiting Procter & Gamble's forecast page.

What is Procter & Gamble's operating income?

Procter & Gamble's total operating income in 2024 was $18.55 billion, based on the following breakdown:

Total Gross Profit: $43.19 billion
Total Operating Expenses: $24.65 billion

How has Procter & Gamble revenue changed over the last 9 years?

Over the last 9 years, Procter & Gamble's total revenue changed from $70.75 billion in 2015 to $84.04 billion in 2024, a change of 18.8%.

How much debt does Procter & Gamble have?

Procter & Gamble's total liabilities were at $71.81 billion at the end of 2024, a 2.6% decrease from 2023, and a 8.1% increase since 2015.

How much cash does Procter & Gamble have?

In the past 9 years, Procter & Gamble's cash and equivalents has ranged from $0.00 in 2020 to $10.29 billion in 2021, and is currently $9.48 billion as of their latest financial filing in 2024.

How has Procter & Gamble's book value per share changed over the last 9 years?

Over the last 9 years, Procter & Gamble's book value per share changed from 22.61 in 2015 to 20.97 in 2024, a change of -7.3%.

Related Companies

This page (NYSE:PG) was last updated on 5/20/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Procter & Gamble (PG) Financials

Frequently Asked Questions About Procter & Gamble's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Procter & Gamble (PG) Financials

Annual Income Statements for Procter & Gamble

Quarterly Income Statements for Procter & Gamble

Annual Cash Flow Statements for Procter & Gamble

Quarterly Cash Flow Statements for Procter & Gamble

Annual Balance Sheets for Procter & Gamble

Quarterly Balance Sheets for Procter & Gamble

Annual Metrics And Ratios for Procter & Gamble

Quarterly Metrics And Ratios for Procter & Gamble

Frequently Asked Questions About Procter & Gamble's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools